236 related articles for article (PubMed ID: 25674647)
1. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
Mönig SP; Berlth F; Chon SH
Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
[No Abstract] [Full Text] [Related]
2. Surveillance Following Treatment of Esophageal Cancer.
Bakhos CT; Acevedo E; Petrov RV; Abbas AE
Surg Clin North Am; 2021 Jun; 101(3):499-509. PubMed ID: 34048769
[TBL] [Abstract][Full Text] [Related]
3. Management of gastroesophageal junction tumors.
Fox MP; van Berkel V
Surg Clin North Am; 2012 Oct; 92(5):1199-212. PubMed ID: 23026278
[TBL] [Abstract][Full Text] [Related]
4. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation.
Taketa T; Correa AM; Suzuki A; Blum MA; Chien P; Lee JH; Welsh J; Lin SH; Maru DM; Erasmus JJ; Bhutani MS; Weston B; Rice DC; Vaporciyan AA; Hofstetter WL; Swisher SG; Ajani JA
Oncology; 2012; 83(5):300-4. PubMed ID: 22964903
[TBL] [Abstract][Full Text] [Related]
5. [Non-metastatic oesophageal cancer: diagnosis and treatment].
Voeten DM; den Bakker CM; Goedegebuure RSA; Heineman DJ; Daams F; van der Peet DL
Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556490
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of recurrence patterns in esophageal carcinoma after surgery alone and surgery after neoadjuvant chemoradiotherapy: a secondary analysis of the CROSS study].
Hautmann MG; Kölbl O
Strahlenther Onkol; 2014 Jul; 190(7):696-8. PubMed ID: 25061651
[No Abstract] [Full Text] [Related]
7. [Limitations of surgery for cancer of the upper gastrointestinal tract].
Karakas E; Oetzmann von Sochaczewski C; Haist T; Pauthner M; Lorenz D
Chirurg; 2014 Mar; 85(3):186-91. PubMed ID: 24526142
[TBL] [Abstract][Full Text] [Related]
8. Optimal management of esophageal adenocarcinoma: should we be CROSS?
Smyth EC; Waddell TS; Cunningham D
J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
[No Abstract] [Full Text] [Related]
9. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
[TBL] [Abstract][Full Text] [Related]
10. Multimodal treatment of esophageal cancer.
Lordick F; Hölscher AH; Haustermans K; Wittekind C
Langenbecks Arch Surg; 2013 Feb; 398(2):177-87. PubMed ID: 22971784
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis and management of esophageal and gastric cancer.
Lang GD; Konda VJ
Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
[TBL] [Abstract][Full Text] [Related]
12. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
Smithers BM; Thomson I
Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
[TBL] [Abstract][Full Text] [Related]
15. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
[No Abstract] [Full Text] [Related]
16. Combination chemoradiation therapy: the whole is more than the sum of the parts.
Mamon HJ; Tepper JE
J Clin Oncol; 2014 Feb; 32(5):367-9. PubMed ID: 24419110
[No Abstract] [Full Text] [Related]
17. Reply to E. C. Smyth et al.
Hulshof MC; Oppedijk V; van der Gaast A
J Clin Oncol; 2014 Sep; 32(27):3081-2. PubMed ID: 25071131
[No Abstract] [Full Text] [Related]
18. Reply to E. C. Smyth et al.
Mamon HJ; Tepper JE
J Clin Oncol; 2014 Sep; 32(27):3082. PubMed ID: 25071102
[No Abstract] [Full Text] [Related]
19. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]